High-throughput cell analysis using multiplexed array technologies

Drug Discovery Today

Volumn 7, Issue 18, 2002, Pages S131-S135

  Beske, Oren E ^a   Goldbard, Simon ^a  

^a Virtual Arrays   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; CELL ASSAY; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DATA BASE; DNA HYBRIDIZATION; DNA MICROARRAY; HUMAN; NUCLEIC ACID ANALYSIS; REVIEW; SCREENING TEST; STRUCTURE ACTIVITY RELATION; TIME;

ANIMALS; BIOLOGICAL ASSAY; DRUG EVALUATION, PRECLINICAL; HUMANS; PROTEIN ARRAY ANALYSIS;

EID: 0037107027     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(02)02388-7     Document Type: Review

References (23)

1. HighTech Business Decisions (2000) Executive summary. In High-Throughput Screening 2000: New Trends and Directions. pp. 1-1-1-20, Moraga, CA, USA (available online at http://www.hitechbiz.com)
2. Durick K., Negulescu P. Cellular biosensors for drug discovery. Biosens. Bioelectron. 16:2001;587-592.
3. Giuliano K., Taylor L. Fluorescent-protein biosensors: new tools for drug discovery. Trends Biotechnol. 16:1998;135-140.
4. Tsien R. Rosy dawn for fluorescent proteins. Nat. Biotech. 17:1999;956-957.
5. Miraglia S., et al. Homogeneous cell- and bead-based assays for high-throughput screening using fluorometric mircovolume assay technology. J. Biomol. Screening. 4:2000;193-204.
6. Jurewicz A., et al. Fluorometric imaging plate reader: using orexin receptor to screen 145,000 compounds. Genet. Eng. News. 19:1999;44-46.
7. Mattheakis L., et al. Expression of Cre recombinase as a reporter of signal transduction in mammalian cells. J. Biol. Chem. 6:1999;835-844.
8. Ghosh R., et al. Cell-based, high-content screen for receptor internalization, recycling and intracellular trafficking. Biotechniques. 29:2000;170-175.
9. Hertzberg R., Pope A. High-throughput screening: new technology for the 21st century. Curr. Opin. Chem. Biol. 4:2000;445-451.
10. Blake R. Cellular screening assays using fluorescence microscopy. Curr. Opin. Pharmacol. 1:2001;533-539.
11. Taylor L., et al. Real-time molecular and cellular analysis: the new frontier of drug discovery. Curr. Opin. Biotechnol. 12:2001;75-81.
12. Sundberg S. High-throughput and ultra-high-throughput screening: solution- and cell-based approaches. Curr. Opin. Biotechnol. 11:2000;47-53.
13. Gonzales J., et al. Cell-based assays and instrumentation for screening ion-channel targets. Drug Discov. Today. 4:1999;431-439.
14. Martins, T.B. (2002) Development of internal controls for the Luminex instrument as part of a multiplex seven-analyte viral respiratory antibody profile. Clin. Diagn. Lab. Immunol. January, 41-45
15. Kapur R., et al. Streamlining the drug discovery process by integrating miniaturization, high throughput screening, high content screening, and automation on the CellChip™ system. Biomed. Microdevices. 2:1999;99-109.
16. Ziauddin J., Sabatini D. Microarrays of cells expressing defined cDNAs. Nature. 411:2001;107-110.
17. Miller K. Downsizing DNA assays. The Scientist. 16:2002;52.
18. Ianmone M.A., et al. Mulitplexed molecular interactions of nuclear receptors using fluorescent microspheres. Cytometry. 44:2001;326-337.
19. Nicewarner-Pena S., et al. Submicrometer metallic barcodes. Science. 294:2001;137-141.
20. Bruchez M., et al. Semiconductor nanocrystals as fluorescent biological labels. Science. 281:1998;2013-2015.
21. Chan W., Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science. 281:1998;2016-2018.
22. Han M., et al. Quantum-dot-tagged microbeads for mulitplexed optical coding of biomolucules. Nat. Biotechnol. 19:2001;631-635.
23. Chan W., et al. Luminescent quantum dots for multiplexed biological detection and imaging. Curr. Opin. Biotechnol. 13:2002;40-46.